CIPLA MEDPRO SOUTH AFRICA LIMITED - Dealing in securities by directors of a major subsidiary

Dealing in securities by directors of a major subsidiary

CIPLA MEDPRO SOUTH AFRICA LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
ISIN Number: ZAE000128179
 Share Code: CMP
("Cipla Medpro" or “CMSA” or "the Company")

DEALING IN SECURITIES BY DIRECTORS OF A MAJOR SUBSIDIARY

In terms of paragraph 3.63 – 3.65 of the JSE Limited Listings Requirements, the following
information relates to the dealing in securities by directors of a major subsidiary of Cipla Medpro:

Employee:                                Mr H Grobler
Office held:                             Executive director of a major subsidiary, Medpro
                                         Pharmaceutica Proprietary Limited
Number of shares:                        150 000
Strike price:                            R6.82 per share1
Value of transaction:                    R1 023 000
Extent of interest:                      Direct beneficial
Date of transaction:                     26 April 2013
Nature of transaction:                   Grant and acceptance of share options in terms of the
                                         CMSA Employee Share Option Scheme (off market)
Vesting periods:                         15 000 shares on 22 April 2015 or thereafter
                                         45 000 shares on 22 April 2016 or thereafter
                                         45 000 shares on 22 April 2017 or thereafter
                                         45 000 shares on 22 April 2018 or thereafter
Written clearance to deal obtained:      Yes

Employee:                                Mr R van der Westhuizen
Office held:                             Executive director of a major subsidiary, Medpro
                                         Pharmaceutica Proprietary Limited
Number of shares:                        150 000
Strike price:                            R6.82 per share1
Value of transaction:                    R1 023 000
Extent of interest:                      Direct beneficial
Date of transaction:                     26 April 2013
Nature of transaction:                   Grant and acceptance of share options in terms of the
                                         CMSA Employee Share Option Scheme (off market)
Vesting periods:                         15 000 shares on 22 April 2015 or thereafter
                                         45 000 shares on 22 April 2016 or thereafter
                                         45 000 shares on 22 April 2017 or thereafter
                                         45 000 shares on 22 April 2018 or thereafter
Written clearance to deal obtained:      Yes

Note:

1  On 15 October 2012, the Board of Directors (“the Board”) of Cipla Medpro had resolved to offer the
share options to Mr H Grobler and Mr R van der Westhuizen and, in terms of the CMSA Employee Share
Option Scheme, the price applicable to such share options is the 30 day volume weighted average price
of the shares on the JSE at the date the Board resolves to offer the shares, i.e. R6.82 per share at 15
October 2012. Until 26 March 2013, the company was prohibited from granting the share options to
these directors.

Durban
26 April 2013
Sponsor
Nedbank Capital

Date: 26/04/2013 04:50:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.